JP2022520183A5 - - Google Patents
Info
- Publication number
- JP2022520183A5 JP2022520183A5 JP2021546362A JP2021546362A JP2022520183A5 JP 2022520183 A5 JP2022520183 A5 JP 2022520183A5 JP 2021546362 A JP2021546362 A JP 2021546362A JP 2021546362 A JP2021546362 A JP 2021546362A JP 2022520183 A5 JP2022520183 A5 JP 2022520183A5
- Authority
- JP
- Japan
- Prior art keywords
- drug delivery
- composition according
- delivery composition
- poly
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025021232A JP2025093918A (ja) | 2019-02-08 | 2025-02-13 | 治療物質の眼投与のための薬物送達組成物及びその使用法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962803388P | 2019-02-08 | 2019-02-08 | |
| US62/803,388 | 2019-02-08 | ||
| PCT/US2020/017523 WO2020163871A1 (en) | 2019-02-08 | 2020-02-10 | Drug delivery compositions for ocular administration of therapeutics and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025021232A Division JP2025093918A (ja) | 2019-02-08 | 2025-02-13 | 治療物質の眼投与のための薬物送達組成物及びその使用法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022520183A JP2022520183A (ja) | 2022-03-29 |
| JP2022520183A5 true JP2022520183A5 (enExample) | 2023-03-03 |
| JP7636334B2 JP7636334B2 (ja) | 2025-02-26 |
Family
ID=71947905
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546362A Active JP7636334B2 (ja) | 2019-02-08 | 2020-02-10 | 治療物質の眼投与のための薬物送達組成物及びその使用法 |
| JP2025021232A Pending JP2025093918A (ja) | 2019-02-08 | 2025-02-13 | 治療物質の眼投与のための薬物送達組成物及びその使用法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025021232A Pending JP2025093918A (ja) | 2019-02-08 | 2025-02-13 | 治療物質の眼投与のための薬物送達組成物及びその使用法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220117888A1 (enExample) |
| EP (1) | EP3921420B1 (enExample) |
| JP (2) | JP7636334B2 (enExample) |
| KR (1) | KR20210138596A (enExample) |
| CN (1) | CN113710806A (enExample) |
| AU (1) | AU2020219436A1 (enExample) |
| BR (1) | BR112021015565A2 (enExample) |
| CA (1) | CA3129423A1 (enExample) |
| MX (1) | MX2021009526A (enExample) |
| WO (1) | WO2020163871A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3886946A1 (en) | 2019-06-05 | 2021-10-06 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| WO2021262645A1 (en) * | 2020-06-22 | 2021-12-30 | Ohio State Innovation Foundation | Redox-responsive nanoparticle compositions for ocular delivery of therapeutics |
| US20230392150A1 (en) * | 2020-10-13 | 2023-12-07 | The Asan Foundation | Composition for treating retinal or choroidal diseases, containing acta2 inhibitor as active ingredient |
| EP4317311A4 (en) * | 2021-03-30 | 2025-04-09 | Zeon Corporation | CONTAINER |
| EP4322923A1 (en) | 2021-04-16 | 2024-02-21 | Fondazione Istituto Italiano di Tecnologia | Polymeric microparticles for the local treatment of chronic inflammatory diseases |
| EP4358944A4 (en) * | 2021-06-21 | 2025-03-12 | William Marsh Rice University | HIGH-YIELD PREPARATION OF PULSATILE-RELEASE MICROPARTICLES |
| CN113737393B (zh) * | 2021-09-15 | 2022-06-07 | 陕西环保产业研究院有限公司 | 一种静电纺丝纳米纤维膜及其制备方法 |
| US20230355533A1 (en) * | 2022-05-06 | 2023-11-09 | University Of Cincinnati | Biodegradable polycaprolactone capsule for antibody release and degradation |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| CN120478308B (zh) * | 2025-07-17 | 2025-09-09 | 乐比(广州)健康产业有限公司 | 一种基于天然提取物的护眼组合物及其制备工艺 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5516522A (en) * | 1994-03-14 | 1996-05-14 | Board Of Supervisors Of Louisiana State University | Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same |
| US7838037B2 (en) * | 1999-11-17 | 2010-11-23 | Tagra Biotechnologies Ltd. | Method of microencapsulation |
| WO2006088473A2 (en) * | 2004-04-23 | 2006-08-24 | Panduranga Rao Koritala | Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents |
| CN101137369A (zh) * | 2005-02-09 | 2008-03-05 | 马库赛特公司 | 用于眼治疗的制剂 |
| US20110038939A1 (en) * | 2007-07-16 | 2011-02-17 | Northeastern University | Therapeutic stable nanoparticles |
| EP2560576B1 (en) * | 2010-04-22 | 2018-07-18 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
| US9636309B2 (en) * | 2010-09-09 | 2017-05-02 | Micell Technologies, Inc. | Macrolide dosage forms |
| CN104244964A (zh) * | 2012-02-22 | 2014-12-24 | 康肽德生物医药技术有限公司 | 用于预防或治疗眼科病状的方法和组合物 |
| WO2013126799A1 (en) * | 2012-02-22 | 2013-08-29 | Trustees Of Tufts College | Compositions and methods for ocular delivery of a therapeutic agent |
| JP2015510818A (ja) * | 2012-03-20 | 2015-04-13 | トラスティーズ オブ タフツ カレッジ | 薬物送達のための絹リザーバー |
| WO2015142855A1 (en) * | 2014-03-17 | 2015-09-24 | University Of Virginia Patent Foundation | Compositions and methods for treating retinopathy |
-
2020
- 2020-02-10 KR KR1020217028718A patent/KR20210138596A/ko active Pending
- 2020-02-10 AU AU2020219436A patent/AU2020219436A1/en not_active Abandoned
- 2020-02-10 CN CN202080027514.XA patent/CN113710806A/zh active Pending
- 2020-02-10 BR BR112021015565-1A patent/BR112021015565A2/pt unknown
- 2020-02-10 MX MX2021009526A patent/MX2021009526A/es unknown
- 2020-02-10 WO PCT/US2020/017523 patent/WO2020163871A1/en not_active Ceased
- 2020-02-10 EP EP20752549.4A patent/EP3921420B1/en active Active
- 2020-02-10 CA CA3129423A patent/CA3129423A1/en active Pending
- 2020-02-10 US US17/428,616 patent/US20220117888A1/en active Pending
- 2020-02-10 JP JP2021546362A patent/JP7636334B2/ja active Active
-
2025
- 2025-02-13 JP JP2025021232A patent/JP2025093918A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022520183A5 (enExample) | ||
| JP6882186B2 (ja) | スニチニブ製剤及び眼の障害の治療におけるその使用に対する方法 | |
| Jiang et al. | Progress on ocular siRNA gene‐silencing therapy and drug delivery systems | |
| CN104363924B (zh) | 用于递送hif‑1抑制剂的控制释放调配物 | |
| US10369124B2 (en) | Dendrimer compositions and their use in treatment of diseases of the eye | |
| US20170173161A1 (en) | Compositions and methods for ocular delivery of a therapeutic agent | |
| JP2015508104A5 (enExample) | ||
| CN107184544A (zh) | 前房内持续释放治疗药植入物 | |
| JP5702152B2 (ja) | 眼疾患治療用組成物及び方法 | |
| NZ725574A (en) | Compounds for treating ophthalmic diseases and disorders | |
| CN102233129B (zh) | 一种预防或治疗视网膜损伤的长效缓释制剂及其制备方法 | |
| JP2022520183A (ja) | 治療物質の眼投与のための薬物送達組成物及びその使用法 | |
| JP2021521173A (ja) | 眼内薬物送達用の持続放出微粒子のための方法及び組成物 | |
| Ugurlu et al. | Transscleral delivery of bevacizumab-loaded chitosan nanoparticles | |
| Shen et al. | Nanostructured drug delivery systems for posterior segment eye diseases: Strategies to defy ocular barriers | |
| Sabbagh et al. | Hydrogel-based ocular drug delivery systems | |
| JP2018536650A5 (enExample) | ||
| JP2013523748A5 (enExample) | ||
| US20250092013A1 (en) | Prodrugs of axitinib | |
| Liu et al. | Application of nanomaterials in the treatment and diagnosis of ophthalmology diseases | |
| C Gilger et al. | Episcleral, Intrascleral, and Suprachoroidal Routes of Ocular Drug Delivery–Recent Research Advances and Patents | |
| EP4251204A1 (en) | Vegf antagonist for use in methods for treating ocular diseases | |
| RU2021126314A (ru) | Композиции для доставки лекарственных средств для офтальмологического введения терапевтических средств и способы их применения | |
| CN108938600B (zh) | 玻璃体内注射的对抗体药物双重保护的微球及其制备方法 | |
| TW202448436A (zh) | 含有酪胺酸激酶抑制劑之眼部植入物 |